March 2013
| Find and Apply
|
|
|
Greetings!
We hope that you find this publication helpful in your funding search. We also encourage you to visit our intranet funding page, which offers more information on funding resources available to faculty and fellows.
|
DFCI Limited Applications
|
The next DFCI Limited Application deadline is Wednesday, April 3rd, 3:00 pm to apply for the V Foundation's Translational Grant. The internal applicant must have an appointment of Instructor or above; and the project team must have a minimum of two scientists from DFCI and must possess basic and clinical research expertise.
DFCI Limited Application Process
|
|
|
|
Internal Funding DFCI, DF/HCC, BWH, and Harvard Dana-Farber Harvard Cancer Center (DF/HCC) A. David Mazzone Research Awards Program This program will fund a series of collaborative and innovative cancer research, career development, community outreach, and training projects to address a range of needs in prostate cancer and Lupron-treatable diseases. Funding Agency: The funding agency for the Program is a grant from the U.S. District Court for the District of Massachusetts of a pool of unclaimed funds from the 2004 class action suit settlement by TAP Pharmaceuticals. The class action suit was related to marketing and sales practices for the prostate cancer drug Lupron. The program is administered jointly through DF/HCC and the Prostate Cancer Foundation.
Amount: Varies By Mechanism Deadline: April 5, 2013
Dana-Farber Harvard Cancer Center (DF/HCC) Clinical Research Career Development Program - K12The DF/HCC Advisory Committee is currently seeking applicants for the K12 Paul Calabresi Award for Clinical Oncology (PCACO) entitled "Clinical Research Career Development Program." Funding for two new awardees will be available retroactive to April 1, 2013. The recipient must devote a minimum of 75% effort to the Clinical Research Career Development Program. Amount: $100,000/year for up to 5 years Deadline: May 1, 2013 |
|
Non-Federal Funding - Grants
Association for International Cancer Research (AICR)
Research GrantAICR's goal is to fund scientific research that may, in the future, help reduce the incidence of cancer or improve cancer survival. AICR awards project grants between 12 and 36 months to support basic and translational research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. AICR will consider applications in which studies on patients, volunteers, clinical records or human tissue are used to address a basic scientific question. Amount: £200,000 (~$300,000) over 3 years Deadline: April 26, 2013
| Melanoma Research Foundation
Established Investigator AwardProvides support for promising medical research that will further the goal of developing an effective treatment and possible cure of malignant melanoma, while encouraging scientists and clinicians to join in this mission. The award is given to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Emphasis will be placed on projects that explore innovative approaches to understanding melanoma and its treatment. Both basic and clinical research projects will be considered. Each principal investigator or head of laboratory is limited to one application per year.
Amount: $100,000/year for 2 years Deadline: May 1, 2013
Melanoma Research Foundation Career Development Award Provides emerging scientific investigators with highly sought-after research grants that allow them to explore new avenues in melanoma biology and treatments, ultimately leading to a cure. This program emphasizes both basic and clinical research projects that explore innovative approaches to understanding melanoma and its treatment. Amount: $50,000/year for 2 years
Deadline: May 1, 2013 Prostate Cancer Foundation (PCF) 2013 Challenge Award For Metastatic Prostate Cancer PCF is interested in supporting large-scale research projects concerning metastatic prostate cancer. Projects must focus on Treatment Sciences: Investigations of new ideas in man or laboratory support of a high-impact clinical investigation with a high probability of near-term patient benefit. Teams should be composed of at least 3 highly experienced investigators as well as a young investigator. Teams may be assembled from one institution, or several institutions, from across the globe. Amount: $1 million over 2 years
Deadline: May 24, 2013 Lung Cancer Research Foundation (LCRF) LCRF Grant Program LCRF welcomes submissions of grant requests for funding covering all aspects of lung cancer. Grants are awarded for lung cancer projects focused on: basic science; translational research; clinical research; supportive care; quality of care/outcomes.
Amount: $50,000 for 1 year
Deadline: May 31, 2013 The Doctors Cancer FoundationResearch GrantProvides funds to promote young scientists currently under the radar screen. Grants will be awarded for the best program in the management of cancer. The sponsor is particularly interested in cancer stem cells, microRNAi agents, epigenetic agents, as well as many others topics. The sponsor is not looking at drug studies. The project should be innovative, sound and be able to lead to clinical trials. Amount: $50,000 for 1 year Deadline: May 31, 2013 Leukemia & Lymphoma Society (LLS) The Quest For CuresThis program aims to identify and develop safer, more effective treatment paradigms for patients with hematological malignancies. LLS has formed a partnership with Celgene to build the foundation of this new LLS initiative. This initiative will identify and fund priority research areas, with support from biotech and pharmaceutical partners in order to address significant unmet medical needs. The near-term goal of this program is to advance the scientific and medical understanding of the various hematological malignances. Amount: $200,000 - $400,000/year for 2 years Deadline: LOI: June 3, 2013 Innovation Award
Provides support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Amount: $150,000/year for 3 years Deadline: July 1, 2013 Oncology Nursing Society (ONS) Research Career Development AwardProvides support for short-term oncology research training and mentorship. The applicant must be a registered nurse with an interest in oncology and with a completed PhD degree in nursing or a related discipline. The conduct of a research project (including pilot and feasibility studies) is not permitted for this funding mechanism. Amount: $20,000 for 1 year Deadline: July 1, 2013 Oncology Nursing Society (ONS) Research Grant AwardsThese grants support oncology nursing research. Research projects may include pilot or feasibility studies or the development of a new aspect of a program of research. The principal investigator must be actively involved in some aspect of cancer patient care, education, or research, and be PhD- or DNSc-prepared or a student working toward one of those research degrees. Funding preference is given to projects that involve nurses in the design and conduct of the research activity and that promote theoretically based oncology practice. Membership in ONS is not required for eligibility. Amount: $25,000 over 2 years Deadline: LOI: August 15, 2013 Leukemia & Lymphoma Society (LLS) Career Development Program (CDP) The Career Development Program (CDP) offers the opportunity to take part in basic, clinical or translational research to help treat leukemia, lymphoma and myeloma. LLS will award stipends so the applicant can devote time to leukemia research, lymphoma research or myeloma research. LLS offers career development awards for various stages of an applicant's research career. Please verify in the guidelines and instructions which award is appropriate for the applicant's level of experience and apply to that category of award: Amount: Varies By Mechanism Deadline: LOI: September 15, 2013 All applications are due into the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review and approval prior to submission to the sponsor.
|
Non-Federal Funding - Fellowships
Multiple Myeloma Research Foundation Research Fellow Awards Provides funding to researchers at the post doctorate/medical fellow or junior faculty levels and working under the supervision or guidance of a research sponsor in the multiple myeloma field. Amount: $75,000 for 1 year Deadline: May 14, 2013 Damon Runyon Cancer Research Foundation |
All Fellowships are due into the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review and approval prior to submission to the sponsor.
|
Search for Funding Using SPIN DFCI subscribes to InfoEd International SPIN ™
SPIN
InfoEd's SPIN (Sponsored Programs Information Network) currently contains information from more than 10,000 different sponsoring agencies, which together fund over 40,000 separate funding opportunities. Options include features such as: Quick Search, Advanced Searching Capabilities, and the Federal Register. Please see the ' Training Videos' on the SPIN site for more information on SPIN and its features. Please ensure that you have logged into InfoEd in the web browser you are using, otherwise you will not be able to access SPIN.
| |
|
|
|
|